EDUARD KRAYCHIK: Open Payments
NPI 1689611196 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$708 in 26 payments from 7 companies in 2025. Trend: 2023 $225 · 2024 $675 · 2025 $708
Food & beverage: $708
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $388 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $112 |
| Axsome Therapeutics, Inc. | 5 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| PFIZER INC. | 2 | $28 |
| Lundbeck LLC | 2 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: VRAYLAR, CAPLYTA, Auvelity, REXULTI, TRINTELLIX, ELIQUIS.
Industry payments across PA — which companies pay providers there.
